RT @RHEUMarampa: Post hoc analysis of pooled data from 19 clin trials on SEC & CV risk & systemic #inflammation
Tweet Content
Post hoc analysis of pooled data from 19 clin trials on SEC & CV risk & systemic #inflammation in PsO, PsA, AS
📌Traditional CV parameters remained stable on all SEC treated grps
📌SEC sig. ⬇hsCRP & NLR
@RheumNow #ACR21 abs1835 https://t.co/iCaGFbXNXn
Show on Archive Page
On
Display in Search Results
On
PDQ
Off